MycoMedica Life Sciences, PBC
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| May 2021 | $23 M | No. 1 | $10 to $50 million | equity | SEC |
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
MycoMedica Life Sciences, PBC chose not to state its revenue in its newest notice of a funding round (Dec 2021).
SEC Form D · Dec 2021
The industry group it chose in its notices: Biotechnology.
SEC Form D · Dec 2021
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of MycoMedica Life Sciences, PBC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| John Parrish | Executive officer | Dec 2021 |
| Paul Stamets | Executive officer | Dec 2021 |
| Tad Buchanan | Executive officer | Dec 2021 |
| James Joaquin | Director | Dec 2021 |
| Pamela Kryskow | Director | Dec 2021 |
| Paul Stamets | Director | Dec 2021 |
| Tad Buchanan | Director | Dec 2021 |
| Paul Stamets | Promoter | Dec 2021 |